华金资本(000532.SZ)拟定增募资不超7.1亿元 控股股东参与认购
格隆汇1月19日丨华金资本(000532.SZ)披露2021年非公开发行A股股票预案,此次非公开发行募集资金总额不超过7.1亿元(含此数),扣除发行费用后的募集资金净额拟全部用于以下项目:约5.45亿元用于智汇湾创新中心项目;约1.65亿元用于偿还银行贷款及补充流动资金。
此次非公开发行股票的发行对象为包括控股股东华实控股在内的不超过35名特定投资者。华实控股拟以现金方式认购此次非公开发行的A股股票,拟认购此次非公开发行股票最终发行数量的28.45%。此次非公开发行股票的交易构成关联交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.